I have been doing other things since 2004 and not following pharma and biotech closely. It appears that what has happened is large pharma invested in systems biology in the early 2000's and by the end of the decade had let it fade. It may also be true that it never made it into specific disease groups, like neurological.
Systems Biology feels a little like AI in the software field. It feels so intuitive that it will one day make a big difference, but there have been many big investments and disappointments over the years, but each time it makes a resurgence we get a lot of advancement in narrow domains. And, it still feels like one day, maybe soon we will get breakthrough's in more general AI and maybe you will lead the way with SB.
A certain confidence, even brashness of youth is ok, but please understand how "tinny" it sounds to people who have been around for one or two boom/bust cycles. Forgive us our cynicism.
Also regarding articles, please email me at [email protected] and I will send you PDF versions to read.